Auricular Acupressure for Perimenopausal Insomnia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-55
SponsorThe First Affiliated Hospital of Zhejiang Chinese Medical University

About this trial

This clinical trial aims to determine whether auricular Acupressure therapy can improve symptomatic insomnia in perimenopausal women.

Can ear acupressure therapy significantly improve sleep quality in perimenopausal women with insomnia? What medical issues or adverse reactions might participants experience during the treatment? Researchers will compare ear acupressure therapy with traditional treatments in a control group to assess its effectiveness and safety.

Participants will:

Receive auricular acupressure on Monday and Thursday, applying pressure for 3 consecutive days each week. This process will continue for 4 weeks, totaling 8 sessions.

Record assessment points as follows: Baseline (2 weeks before treatment to Week 0), mid-treatment (2 weeks after treatment begins), end of treatment (4 weeks after treatment begins), and follow-up (4 weeks after treatment ends) for primary and secondary outcome indicators. Eight weeks after treatment concludes, only the primary outcome indicator (Insomnia Severity Index) will be recorded.

This trial seeks to evaluate the potential benefits and safety profile of auricular acupressure therapy for managing insomnia in perimenopausal women.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 45 and 55 years;

Meetingperimenopause defined by the Staging of Reproductive Aging Workshop (STRAW);

Patients must satisfy at least one diagnostic criterion for insomnia in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); ④ Nighttime sleep disturbances and associated perimenopausal symptoms persisting for at least 4 weeks; ⑤ No use, or stable long-term use (>2 months) of medications for treating insomnia;

No prior auricular acupuncture therapy, good compliance, understanding of the study protocol, and signed informed consent.

Disqualifiers

Does not meet inclusion criteria;

Non-natural menopausal transition due to premature ovarian failure, drug intake, or surgeries (e.g., oophorectomy);

Currently pregnant or breastfeeding;

Insomnia caused by systemic diseases (e.g., stroke, Parkinson's disease, surgery, etc.);

Trial design

Design model

Parallel

Treatments tested in this trial

  • Auricular point compression

    Behavioral

    Acupuncture Points: Endocrine, Sympathetic, Shenmen, Heart Procedure Instructions: Disinfect the areas with 75% alcohol as per standard precautions. Treatments use only ear patches without Vaccaria seeds applied to these specific acupuncture points. Treatment sessions occur every Monday and Thursday. On Mondays, left ears are patched for three continuous days. Then on Thursdays, qualified medical personnel will remove the patches from the left ear and apply new patches to the right ear for four consecutive days. Any replacements must be performed at the hospital by qualified staff; patients should not attempt to do this themselves. This procedure is repeated weekly over a span of four weeks, resulting in eight total applications. Importantly, patients in this group do not perform acupoint stimulation as part of their treatment.

  • No pressure on the ear point

    Behavioral

    Acupuncture Points: Endocrine, Sympathetic, Shenmen, Heart Procedure Instructions: Disinfect the areas with 75% alcohol as per standard precautions. Treatments use only ear patches without Vaccaria seeds applied to these specific acupuncture points. Treatment sessions occur every Monday and Thursday. On Mondays, left ears are patched for three continuous days. Then on Thursdays, qualified medical personnel will remove the patches from the left ear and apply new patches to the right ear for four consecutive days. Any replacements must be performed at the hospital by qualified staff; patients should not attempt to do this themselves. This procedure is repeated weekly over a span of four weeks, resulting in eight total applications. Importantly, patients in this group do not perform acupoint stimulation as part of their treatment.

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: Ear Acupoint Pressing GroupExperimental treatment 1 intervention
Group B: Sham Ear Acupoint Pressing GroupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Insomnia Severe Index

The ISI (Insomnia Severity Index) is a widely used self-assessment tool for evaluating the severity of insomnia. Its total score categorizes the severity of insomnia into four levels: no significant clinical insomnia (0-7 points), mild insomnia (8-14 points), moderate clinical insomnia (15-21 points), and severe clinical insomnia (22-28 points). The internal consistency of the ISI is Cronbach's α = 0.76, indicating good reliability. It is highly sensitive to changes after auricular acupuncture therapy, and a decrease in the ISI score of less than 8 points indicates improvement in insomnia symptoms.

Time frame
Baseline (2 weeks before treatment), pre-treatment (0 days of treatment), mid-treatment (2 weeks after start of treatment), end of treatment (4 weeks after start of treatment), follow-up (4 weeks and 8 weeks after end of treatment)、

Secondary outcomes

1

Pittsburgh sleep quality index

The questionnaire examines in detail the seven key dimensions related to sleep over the past month: sleep duration, sleep disorders, latency to fall asleep, the effects of nighttime sleep on daytime function, sleep efficiency, the use of drugs needed to promote sleep, and overall sleep quality.

Time frame
Baseline (2 weeks before treatment), pre-treatment (0 days of treatment), mid-treatment (2 weeks after start of treatment), end of treatment (4 weeks after start of treatment), follow-up (4 weeks after end of treatment
2

Sleep Diary

Multiple sleep parameters recorded in the sleep diary, including sleep latency, sleep efficiency, total sleep duration, and the number and duration of arousal during sleep. To comprehensively capture the participants' sleep patterns and quality changes, we asked them to fill in the sleep diary carefully daily during the 4-week intervention period and one week before each follow-up visit.

Time frame
Baseline (2 weeks before treatment), pre-treatment (0 days of treatment), mid-treatment (2 weeks after start of treatment), end of treatment (4 weeks after start of treatment), follow-up (4 weeks after end of treatment)
3

Kupperman Index

The KI score is currently widely used internationally to evaluate the severity of symptoms in the menopausal syndrome.

Time frame
Baseline (2 weeks before treatment), pre-treatment (0 days of treatment), mid-treatment (2 weeks after start of treatment), end of treatment (4 weeks after start of treatment), follow-up (4 weeks after end of treatment)
4

Menopause-specificquality of life

MENQOL Scale (total score of 174 points), different from the Kupperman score, patients should fill it out by themselves, and monitor the severity and progression of their symptoms in real time based on their own feelings.

Time frame
Baseline (2 weeks before treatment), pre-treatment (0 days of treatment), mid-treatment (2 weeks after start of treatment), end of treatment (4 weeks after start of treatment), follow-up (4 weeks and 8 weeks after end of treatment)、

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: